Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy Vera Therapeutics stock (Vera Therapeutics)

Buy Vera Therapeutics stock in 5 easy steps, view past price performance and learn what’s ahead for the company.

Vera Therapeutics is a biotechnology business based in the US. Vera Therapeutics shares (VERA) are listed on the NASDAQ and all prices are listed in US Dollars. Vera Therapeutics employs 55 staff and has a market cap (total outstanding shares value) of 0.00.

Our top picks for where to buy Vera Therapeutics stock

Top pick for advanced traders

Go to site
Get up to $5,000 cash
  • Trade options, futures, options on futures, stocks, ETFs
  • $0 commission to close options
  • Pro-grade platform and risk analysis tools

Our pick for transfer bonus

Go to site
Get up to $10,000 cash
  • Trade stocks, options, ETFs, mutual funds, alternative asset funds
  • $0 commission on stocks, ETFs and options, with no options contract fees
  • No-cost financial planning and automated investing

Our pick for Investing by theme

Go to site
Earn up to $300 on new deposits
  • Trade $0 commission stocks & ETFs with as little as $1
  • Theme and ETF screener
  • Discover new opportunities with Opto's AI-driven classification system

How to buy Vera Therapeutics stock

  1. Choose a stock trading platform. Use our comparison table
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – VERA. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Buy Vera Therapeutics stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 5 of 5
Name Product Ratings Available asset types Stock trade fee Minimum deposit Cash sweep APY Signup bonus
Finder Score: 4.4 / 5: ★★★★★
Stocks, Options, ETFs, Cryptocurrency, Futures, Treasury Bills
Get $50-$5,000
Competitive, capped options commissions, with a reliable trading platform designed for serious traders.
SoFi Invest®
Finder Score: 4.2 / 5: ★★★★★
SoFi Invest®
Stocks, Options, Mutual funds, ETFs, Alternatives
Get up to $10,000 cash
Commission-free stocks, ETFs and options, with no options per-contract fees. Plus, a no-cost robo-advisor and complimentary access to certified financial planners (CFPs).
Finder Score: 3.1 / 5: ★★★★★
Stocks, ETFs
Earn up to $300
AI-driven thematic investing, with proprietary research, fractional shares and commission-free stocks and ETFs.
Finder Score: 4.3 / 5: ★★★★★
Stocks, Options, ETFs
Up to 8.10%
Get up to 15 free stocks
No commission stock, ETF and options trades, with $0 equity options contract fees, low margin rates and advanced trading tools.
Finder Score: 4.2 / 5: ★★★★★
Stocks, Bonds, Options, ETFs, Cryptocurrency, Alternatives, Treasury Bills, High-yield cash account
Get up to $10,000 and transfer fees covered
Build a diversified portfolio of stocks, bonds, options, ETFs, crypto and alternative assets, with a high-yield cash account and options contract rebates.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Vera Therapeutics stock price (NASDAQ: VERA)

Use our graph to track the performance of VERA stocks over time.

Vera Therapeutics shares at a glance

Information last updated 2024-07-22.
Latest market close$35.07
52-week range$9.24 - $50.78
50-day moving average $37.68
200-day moving average $29.81
Wall St. target price$56.33
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-2.01

Is it a good time to buy Vera Therapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Vera Therapeutics price performance over time

Historical closes compared with the close of $35.07 from 2024-07-23

1 week (2024-07-17) -0.34%
1 month (2024-06-24) 0.52%
3 months (2024-04-24) -12.22%
6 months (2024-01-24) 106.05%
1 year (2023-07-24) 125.24%
2 years (2022-07-22) 116.08%
3 years (2021-07-23) 99.26%
5 years (2019-07-20) N/A

Vera Therapeutics financials

Gross profit TTM $0
Return on assets TTM -20.25%
Return on equity TTM -36.89%
Profit margin 0%
Book value $6.49
Market Capitalization $1.9 billion

TTM: trailing 12 months

Vera Therapeutics share dividends

We're not expecting Vera Therapeutics to pay a dividend over the next 12 months.

Vera Therapeutics share price volatility

Over the last 12 months, Vera Therapeutics's shares have ranged in value from as little as $9.24 up to $50.78. A popular way to gauge a stock's volatility is its "beta".

VERA.US volatility(beta: 1)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Vera Therapeutics's is 0.996. This would suggest that Vera Therapeutics's shares are less volatile than average (for this exchange).

To put Vera Therapeutics's beta into context you can compare it against those of similar companies.

Vera Therapeutics overview

Vera Therapeutics, Inc. , a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase III clinical trial for patients with immunoglobulin A nephropathy; and for treatment of lupus nephritis that is in Phase II clinical trial. It is also developing MAU868, a human monoclonal antibody for the treatment of BK viremia infections. The company was formerly known as Trucode Gene Repair, Inc. and changed its name to Vera Therapeutics, Inc. in April 2020.

Frequently asked questions

What percentage of Vera Therapeutics is owned by insiders or institutions?
Currently 7.945% of Vera Therapeutics shares are held by insiders and 105.387% by institutions.
How many people work for Vera Therapeutics?
Latest data suggests 55 work at Vera Therapeutics.
When does the fiscal year end for Vera Therapeutics?
Vera Therapeutics's fiscal year ends in December.
Where is Vera Therapeutics based?
Vera Therapeutics's address is: 8000 Marina Boulevard, Brisbane, CA, United States, 94005
What is Vera Therapeutics's ISIN number?
Vera Therapeutics's international securities identification number is: US92337R1014
What is Vera Therapeutics's CUSIP number?
Vera Therapeutics's Committee on Uniform Securities Identification Procedures number is: 923351100

More guides on Finder

Ask a question provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site